Skip to main content
Clinical Trials/RBR-427g9ht
RBR-427g9htNot yet recruitingUnknown

Randomized clinical trial evaluating the Surgical Treatment of large-volume Benign Prostatic Hyperplasia: Endoscopic Enucleation with Holmium Laser x Minimally-invasive Simple Prostatectomy x Bipolar Transurethral Resection of Prostate

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo0 sitesStarted: October 27, 2023Last updated:

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
0 to 0 (—)
Sex
Male

Inclusion Criteria

  • Prostatic volume between 80 and 150mL measured by abdominal ultrasound of the prostate. Present at least one indication criteria for surgical treatment of Benign prostatic hyperplasia (BPH): renal failure with bilateral ureterohydronephrosis, recurrent macroscopic hematúria, acute urinary retention, recurrent urinary tract infection secondary to high post-void volume, moderate to severe voiding urinary symptoms even with clinical treatment interpreted by International Prostate Symptom Score (IPSS) > 15 and/or maximum urinary flow (Qmax) < 12mL/s, moderate to severe voiding urinary symptoms interpreted by International Prostate Symptom Score (IPSS) > 15 and/or maximum urinary flow (Qmax) < 12mL/s in patients intolerant to pharmacological therapy

Exclusion Criteria

  • Prostate câncer. Neurogenic bladder. Previous prostatic surgeries. Bladder stones. Urethral pathologies. Impossibility of suspending anticoagulants or anti-platelet agentes

Investigators

Sponsor
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Similar Trials

Comparison study of the different Surgical... | Clinical Trial